Viewing Study NCT02196961


Ignite Creation Date: 2025-12-24 @ 12:57 PM
Ignite Modification Date: 2026-01-19 @ 1:21 PM
Study NCT ID: NCT02196961
Status: COMPLETED
Last Update Posted: 2025-04-09
First Post: 2014-06-20
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Adjuvant Therapy of Completely Resected Merkel Cell Carcinoma With Immune Checkpoint Blocking Antibodies vs Observation
Sponsor: Prof. Dr. med. Dirk Schadendorf
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: CA184-205
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View